Skip to content

The relationship between Cytochrome P450 polymorphism and therapeutic effects of selective 5-HT reuptake inhibitors in patients with post stroke depression

The relationship between Cytochrome P450 polymorphism and therapeutic effects of selective 5-HT reuptake inhibitors in patients with post stroke depression

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045169
Enrollment
Unknown
Registered
2021-04-07
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke depression

Interventions

genetic typing:none

Sponsors

Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years, with acute phase of stroke (Including a first-ever event or a recurrent stroke); 2. Stroke is defined according to WHO criteria: sudden focal or generalized neurological dysfunction lasting over 24h, including ischemic and hemorrhagic stroke (also including cerebral infarction patients with complete remission after thrombolytic therapy); 3. Patients admitted to hospital with 14 days of stroke onset; 4. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Non-vascular causes of brain dysfunction (primary brain tumormetastatic encephaloma, subdural haematoma, Postseizure paralysiscerebral trauma, et al.); 2. Past history of depression, dementia and psychiatric disorders; 3. Disable on vision, hearing, language; consciousness and comprehension deficits (MMSE<15) , unable to ensure valid assessments; 4. Unable to complete the 1 year follow-up; 5. Transient ischemic attack and Subarachnoidal hemorrhage; 6. Other existing neurological disease (Parkinsons disease, epilepsy, et al).

Design outcomes

Primary

MeasureTime frame
NIH Stroke Scale, NIHSS;HAMD-17; Modified Rankin Scale;Mini Mental State Examination;PHQ-15;BI index;PHQ-9;DNA;

Countries

China

Contacts

Public ContactZhu Suiqiang

Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

zhusuiqiang@163.com+86 13035101141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026